nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C19—urine—polycystic ovary syndrome	0.0345	0.144	CbGeAlD
Carbinoxamine—CYP2C9—urine—polycystic ovary syndrome	0.0267	0.112	CbGeAlD
Carbinoxamine—CYP2E1—urine—polycystic ovary syndrome	0.0253	0.106	CbGeAlD
Carbinoxamine—CYP3A4—urine—polycystic ovary syndrome	0.0204	0.0854	CbGeAlD
Carbinoxamine—CYP2D6—urine—polycystic ovary syndrome	0.0201	0.084	CbGeAlD
Carbinoxamine—Mitotane—CYP11A1—polycystic ovary syndrome	0.0172	0.464	CrCbGaD
Carbinoxamine—Mitotane—SHBG—polycystic ovary syndrome	0.0122	0.327	CrCbGaD
Carbinoxamine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00715	0.03	CbGeAlD
Carbinoxamine—CYP2C8—endometrium—polycystic ovary syndrome	0.00712	0.0298	CbGeAlD
Carbinoxamine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00644	0.027	CbGeAlD
Carbinoxamine—HRH1—endometrium—polycystic ovary syndrome	0.00623	0.0261	CbGeAlD
Carbinoxamine—Chest discomfort—Metformin—polycystic ovary syndrome	0.00614	0.107	CcSEcCtD
Carbinoxamine—CYP2C19—vagina—polycystic ovary syndrome	0.00611	0.0256	CbGeAlD
Carbinoxamine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00572	0.024	CbGeAlD
Carbinoxamine—HRH1—adipose tissue—polycystic ovary syndrome	0.00562	0.0235	CbGeAlD
Carbinoxamine—CYP2C8—vagina—polycystic ovary syndrome	0.00533	0.0223	CbGeAlD
Carbinoxamine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00516	0.0216	CbGeAlD
Carbinoxamine—HRH1—adrenal gland—polycystic ovary syndrome	0.00504	0.0211	CbGeAlD
Carbinoxamine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00499	0.0209	CbGeAlD
Carbinoxamine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00484	0.0203	CbGeAlD
Carbinoxamine—CYP2B6—vagina—polycystic ovary syndrome	0.00478	0.02	CbGeAlD
Carbinoxamine—HRH1—female gonad—polycystic ovary syndrome	0.0047	0.0197	CbGeAlD
Carbinoxamine—HRH1—vagina—polycystic ovary syndrome	0.00467	0.0196	CbGeAlD
Carbinoxamine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.00463	0.125	CrCbGaD
Carbinoxamine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00448	0.0188	CbGeAlD
Carbinoxamine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00443	0.0186	CbGeAlD
Carbinoxamine—HRH1—endocrine gland—polycystic ovary syndrome	0.00437	0.0183	CbGeAlD
Carbinoxamine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00433	0.0757	CcSEcCtD
Carbinoxamine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.0042	0.0176	CbGeAlD
Carbinoxamine—CYP2D6—female gonad—polycystic ovary syndrome	0.00358	0.015	CbGeAlD
Carbinoxamine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00338	0.0142	CbGeAlD
Carbinoxamine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00333	0.0139	CbGeAlD
Carbinoxamine—Sweating increased—Metformin—polycystic ovary syndrome	0.00332	0.0581	CcSEcCtD
Carbinoxamine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.00312	0.0839	CrCbGaD
Carbinoxamine—Drowsiness—Metformin—polycystic ovary syndrome	0.00304	0.0532	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00298	0.0521	CcSEcCtD
Carbinoxamine—Chills—Metformin—polycystic ovary syndrome	0.00245	0.0428	CcSEcCtD
Carbinoxamine—Vision blurred—Metformin—polycystic ovary syndrome	0.00224	0.0391	CcSEcCtD
Carbinoxamine—Tremor—Metformin—polycystic ovary syndrome	0.00222	0.0389	CcSEcCtD
Carbinoxamine—Palpitations—Metformin—polycystic ovary syndrome	0.0021	0.0367	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.0019	0.0332	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00187	0.0328	CcSEcCtD
Carbinoxamine—Anorexia—Metformin—polycystic ovary syndrome	0.00185	0.0323	CcSEcCtD
Carbinoxamine—Hypotension—Metformin—polycystic ovary syndrome	0.00181	0.0317	CcSEcCtD
Carbinoxamine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00174	0.0304	CcSEcCtD
Carbinoxamine—Somnolence—Metformin—polycystic ovary syndrome	0.00172	0.0301	CcSEcCtD
Carbinoxamine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00171	0.0298	CcSEcCtD
Carbinoxamine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00168	0.0295	CcSEcCtD
Carbinoxamine—Fatigue—Metformin—polycystic ovary syndrome	0.00167	0.0292	CcSEcCtD
Carbinoxamine—Constipation—Metformin—polycystic ovary syndrome	0.00166	0.029	CcSEcCtD
Carbinoxamine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0016	0.0279	CcSEcCtD
Carbinoxamine—Urticaria—Metformin—polycystic ovary syndrome	0.00154	0.0269	CcSEcCtD
Carbinoxamine—Asthenia—Metformin—polycystic ovary syndrome	0.00139	0.0243	CcSEcCtD
Carbinoxamine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00133	0.0232	CcSEcCtD
Carbinoxamine—Dizziness—Metformin—polycystic ovary syndrome	0.00128	0.0224	CcSEcCtD
Carbinoxamine—Vomiting—Metformin—polycystic ovary syndrome	0.00123	0.0216	CcSEcCtD
Carbinoxamine—Headache—Metformin—polycystic ovary syndrome	0.00121	0.0212	CcSEcCtD
Carbinoxamine—Nausea—Metformin—polycystic ovary syndrome	0.00115	0.0201	CcSEcCtD
Carbinoxamine—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000307	0.00046	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000306	0.000458	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000305	0.000457	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000303	0.000455	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.0003	0.00045	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.0003	0.00045	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000298	0.000446	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000298	0.000446	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	0.000292	0.000438	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000291	0.000436	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000286	0.000429	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000286	0.000429	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000286	0.000428	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000282	0.000423	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00028	0.000419	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000279	0.000418	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000278	0.000416	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000277	0.000416	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000274	0.000411	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000274	0.00041	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000273	0.000409	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000272	0.000407	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000269	0.000403	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000261	0.000392	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000259	0.000389	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000255	0.000382	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	0.000254	0.000381	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000253	0.000379	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000252	0.000377	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000251	0.000377	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.00025	0.000374	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000249	0.000373	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000248	0.000372	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000248	0.000372	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000248	0.000372	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000248	0.000372	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000248	0.000371	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000247	0.000371	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000245	0.000367	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000243	0.000365	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000243	0.000364	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	0.00024	0.00036	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000239	0.000358	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000237	0.000355	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000236	0.000353	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000236	0.000353	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000235	0.000353	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000235	0.000352	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000233	0.000349	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000233	0.000349	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000231	0.000346	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.00023	0.000345	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00023	0.000345	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000228	0.000341	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000226	0.000338	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000223	0.000334	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000222	0.000333	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000221	0.000332	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000221	0.000331	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000221	0.000331	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000218	0.000327	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000217	0.000325	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000216	0.000324	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000216	0.000323	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000215	0.000322	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	0.000214	0.000321	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000213	0.00032	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.00021	0.000316	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.00021	0.000315	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.00021	0.000315	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000208	0.000312	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	0.000207	0.00031	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000204	0.000305	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000203	0.000304	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.000202	0.000303	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000202	0.000303	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000201	0.000302	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000199	0.000299	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	0.000198	0.000298	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000197	0.000296	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000196	0.000294	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000196	0.000294	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000196	0.000294	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.000194	0.000291	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000194	0.00029	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000192	0.000288	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000192	0.000288	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000192	0.000288	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000191	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00019	0.000284	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000188	0.000281	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000187	0.000281	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000185	0.000277	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000182	0.000273	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000182	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.000181	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000181	0.000272	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000181	0.000271	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00018	0.00027	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000178	0.000268	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000178	0.000267	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000177	0.000265	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000176	0.000265	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000175	0.000262	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.000175	0.000262	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000173	0.000259	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000171	0.000256	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.000168	0.000252	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000167	0.000251	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000167	0.000251	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000167	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000166	0.000249	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000166	0.000248	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000165	0.000247	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000165	0.000247	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000164	0.000246	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000164	0.000246	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000162	0.000243	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000158	0.000237	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—TH—polycystic ovary syndrome	0.000158	0.000236	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000157	0.000235	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000156	0.000235	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.000156	0.000234	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000156	0.000234	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—TH—polycystic ovary syndrome	0.000154	0.000231	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000154	0.000231	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000154	0.000231	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000153	0.00023	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000153	0.000229	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000152	0.000229	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000152	0.000228	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.00015	0.000225	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.00015	0.000225	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000149	0.000224	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000149	0.000223	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000149	0.000223	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000148	0.000222	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000148	0.000221	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000147	0.00022	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000144	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000144	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000144	0.000215	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000144	0.000215	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000143	0.000215	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000142	0.000213	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000141	0.000212	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	0.00014	0.00021	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000138	0.000207	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000138	0.000207	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	0.000138	0.000206	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000137	0.000205	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000136	0.000204	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000136	0.000204	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000136	0.000204	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000135	0.000202	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000134	0.000201	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	0.000133	0.0002	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000133	0.000199	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	0.00013	0.000195	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	0.000129	0.000193	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000129	0.000193	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000128	0.000191	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000127	0.00019	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000127	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	0.000126	0.000189	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000126	0.000189	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000126	0.000188	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	0.000123	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	0.000122	0.000183	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	0.00012	0.00018	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00012	0.00018	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	0.000119	0.000179	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000118	0.000176	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000116	0.000174	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	0.000116	0.000174	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000115	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000114	0.000171	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000113	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.00011	0.000164	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000109	0.000164	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	0.000109	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	0.000109	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000109	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	0.000108	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000107	0.00016	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	0.000106	0.000159	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000106	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	0.000104	0.000156	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000101	0.000151	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000101	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.0001	0.00015	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	9.94e-05	0.000149	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	9.87e-05	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	9.84e-05	0.000148	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.74e-05	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	9.73e-05	0.000146	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	9.39e-05	0.000141	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	9.27e-05	0.000139	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	9.17e-05	0.000138	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.02e-05	0.000135	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.95e-05	0.000134	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.91e-05	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	8.87e-05	0.000133	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.8e-05	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	8.79e-05	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	8.78e-05	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	8.67e-05	0.00013	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	8.62e-05	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	8.61e-05	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	8.52e-05	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	8.49e-05	0.000127	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	8.48e-05	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	8.45e-05	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	8.44e-05	0.000127	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	8.43e-05	0.000126	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	8.41e-05	0.000126	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	8.28e-05	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	8.19e-05	0.000123	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.15e-05	0.000122	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.15e-05	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	8.08e-05	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	8.01e-05	0.00012	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.74e-05	0.000116	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	7.53e-05	0.000113	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	7.47e-05	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	7.44e-05	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	7.34e-05	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	7.3e-05	0.000109	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.16e-05	0.000107	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.97e-05	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	6.64e-05	9.95e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.55e-05	9.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	6.55e-05	9.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	6.51e-05	9.76e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.24e-05	9.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	6.11e-05	9.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	6.05e-05	9.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.02e-05	9.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.99e-05	8.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	5.97e-05	8.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	5.94e-05	8.9e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.85e-05	8.77e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.57e-05	8.35e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.33e-05	7.98e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.28e-05	7.92e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.92e-05	7.38e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.99e-05	5.99e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.94e-05	5.9e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.92e-05	5.87e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	3.68e-05	5.52e-05	CbGpPWpGaD
